JAMA at CCR, Insulin Cost Caps for Medicare Beneficiaries, Mazdutide in Obesity and Orforglipron in Diabetes, and more
Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, Linda Brubaker, MD, Deputy Editor, and Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for articles published from June 6-12, 2026. Related Content: Audio Highlights
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from JAMA Editors' Summary
Implications of the 2026 Dyslipidemia Guidelines, Mechanical Thrombectomy in Ischemic Stroke, Safe Sleep Video Intervention via Text Messaging to Low-Income Families, and more
Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment, YEARS Algorithm for Diagnosis of PE in Patients With Cancer, HPV Screening and Self-Collected Vaginal Samples, and more
Online Prescribing of GLP-1 Receptor Agonists, Alcohol-Related Liver Disease, Survival After Lung Transplant for Select Lung Cancer Patients, and More
Social Media Use by Adults for Health Information, Social Media Use in Children, Managing Familial Hypercholesterolemia, and more
Get summaries like this every morning.
Free AI-powered recaps of JAMA Editors' Summary and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.